![](/assets/images/down.png)
![](/assets/images/up.png)
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
2023-11-02 | 2023-09 | -2.01 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
-
Special sauce that makes vacines work.
Anyone know what company make adjuvant used in GlaxoSmithKline vaccine mentioned in the article?
-
I like that green color!!!
-
I like that green color.
-
Uppps !!! adding some more.!!!
-
What happens to $MRNA if it doesnt make a vaccine that actually works? Would it go up or down? What happens if another company gets the vaccine approved first by fda, would this still go up or down? IMO it would crash if it doesnt get it first
-
When is MRNA going back to 90s? I hope Trump should back off of commenting lowering the price and just deal close door with these company.
-
Moderna’s second-quarter revenue jumps fivefold on coronavirus vaccine development
Berkeley Lovelace Jr.
Moderna reported Wednesday a fivefold increase in second-quarter revenue as the company pursues one of the nation’s leading vaccine candidates to fight Covid-19.Revenue jumped to $66.4 million during the quarter, more than five times the $13.1 million it took in during the same period last year and higher than the $27.4 million projected by analysts surveyed by Refinitiv. The company narrowed its second-quarter loss to $116.7 million, or 31 cents a share, from $134.9 million, or 41 cents a share during the same quarter last year.
-
Here comes the boom !!! Gonna rocket up on the bell !
-
I’m a huge fan of MRNA, PFE, SRNE keep your patience .
I am buying more SRNE, it’s running up to the 30’s. -
$NVAX up 3000% no news coverage
-
Up 3000% and no news coverage!!!!!!
-
Huge GAP
-
Moving up now, this is going to be quick and hard to catch.
-
85$!soon
-
Glad I sold it last week
-
-
Catching it now before it speed up!!
-
Target 95.
-
Target price of 95.
-
-
Bavarian Nordic stock slides on Moderna mpox vaccine study (NASDAQ:MRNA)
news.google.com • -
Moderna updated COVID shot endorsed in EU (NASDAQ:MRNA)
news.google.com • -
Stephen Hoge Sells 318 Shares of Moderna, Inc. (NASDAQ:MRNA) Stock
news.google.com • -
Moderna Stock (MRNA) Nears a Support Level, Is It a Buy?
news.google.com • -
Smart Money Is Betting Big In MRNA Options
news.google.com • -
(MRNA) Trading Advice
news.google.com • -
Moderna CFO sells over $12k in company stock
news.google.com •